AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,943,044 | +289.4% | 115,041 | +85.6% | 0.00% | +200.0% |
| Q2 2020 | $499,000 | +1248.6% | 61,986 | +1127.0% | 0.00% | – |
| Q1 2018 | $37,000 | -81.4% | 5,052 | -79.2% | 0.00% | – |
| Q4 2017 | $199,000 | -95.8% | 24,274 | -94.6% | 0.00% | -100.0% |
| Q3 2017 | $4,712,000 | -7.1% | 448,786 | -2.4% | 0.01% | -11.1% |
| Q2 2017 | $5,072,000 | +38.8% | 459,780 | +21.8% | 0.01% | +28.6% |
| Q1 2017 | $3,654,000 | – | 377,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,673,718 | $20,949,000 | 10.15% |
| Vivo Capital, LLC | 3,575,424 | $28,389,000 | 2.57% |
| COWEN AND COMPANY, LLC | 1,517,296 | $10,767,000 | 2.47% |
| VR Adviser, LLC | 1,057,827 | $8,399,000 | 2.28% |
| RTW INVESTMENTS, LP | 4,616,570 | $36,253,000 | 1.56% |
| GENDELL JEFFREY L | 553,516 | $4,395,000 | 1.35% |
| Avoro Capital Advisors LLC | 4,365,655 | $34,663,000 | 1.17% |
| Arlington Capital Management, Inc. | 115,902 | $920,000 | 0.85% |
| Ghost Tree Capital, LLC | 350,000 | $2,779,000 | 0.74% |
| PURA VIDA INVESTMENTS, LLC | 496,660 | $3,943,000 | 0.47% |